Glenmede Trust’s Vanguard S&P Mid-Cap 400 Value ETF IVOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-650
Closed -$62.2K 1421
2024
Q3
$62.2K Hold
650
﹤0.01% 1312
2024
Q2
$56.9K Hold
650
﹤0.01% 1276
2024
Q1
$59K Sell
650
-650
-50% -$56K ﹤0.01% 1256
2023
Q4
$113K Hold
1,300
﹤0.01% 1194
2023
Q3
$101K Sell
1,300
-650
-33% -$53.4K ﹤0.01% 1145
2023
Q2
$153K Hold
1,950
﹤0.01% 1123
2023
Q1
$153K Hold
1,950
﹤0.01% 1129
2022
Q4
$150K Hold
1,950
﹤0.01% 1121
2022
Q3
$135K Hold
1,950
﹤0.01% 1117
2022
Q2
$140K Sell
1,950
-264
-12% -$20.6K ﹤0.01% 1131
2022
Q1
$185K Buy
+2,214
New +$182K ﹤0.01% 1147
2020
Q2
Sell
-418
Closed -$27K 2534
2020
Q1
$27K Hold
418
﹤0.01% 1931
2019
Q4
$27K Hold
418
﹤0.01% 1931
2019
Q3
$25 Hold
418
﹤0.01% 1934
2019
Q2
$25 Hold
418
﹤0.01% 1971
2019
Q1
$25 Hold
418
﹤0.01% 1982
2018
Q4
$21 Buy
+418
New +$24.5K ﹤0.01% 1968
2018
Q2
Sell
-418
Closed -$25K 2124
2018
Q1
$25K Hold
418
﹤0.01% 1871
2017
Q4
$25K Buy
+418
New +$25K ﹤0.01% 1871

Other funds holding IVOV

Glenmede Trust's IVOV Position: Q4 2024 in Review

Glenmede Trust sold out of Vanguard S&P Mid-Cap 400 Value ETF (IVOV) in Q4 2024, closing a stake of 650 shares — an estimated $62.2K sold.

Glenmede Trust first reported a position in IVOV in Q4 2017 and held it in 19 quarters. The position peaked at $185K in Q1 2022. 147 funds tracked by Wall St. Rank hold IVOV as of Q4 2024.

  • Glenmede Trust reported no remaining Vanguard S&P Mid-Cap 400 Value ETF position as of Q4 2024 after selling out during the quarter.
  • Glenmede Trust sold 650 Vanguard S&P Mid-Cap 400 Value ETF shares in Q4 2024, an estimated $62.2K.
  • Glenmede Trust first reported a position in Vanguard S&P Mid-Cap 400 Value ETF in Q4 2017 and held it in 19 quarters.
  • Glenmede Trust's Vanguard S&P Mid-Cap 400 Value ETF position peaked at $185K in Q1 2022.
  • 147 funds tracked by Wall St. Rank held Vanguard S&P Mid-Cap 400 Value ETF as of Q4 2024.

Based on Glenmede Trust's 13F filing for Q4 2024, filed 14 Feb 2025.